AABB indications
Elective surgeries- Maximum surgical blood ordering schedule
Anemia and surgery- including Transfusion Trigger
Surgery and coagulation disorders- including factor replacement
Transfusion in cardiac surgeries- including autologous transfusion
Patient Blood management in surgery
Allogenic Transfusion
Autologous Transfusion- Intra And Postoperative Red Cell Salvage, Haemodilution
Blood Substitutes
Haematopoietic Factors
Antifibrinolytics
Fibrin Sealants
Conjugated Oestrogens.
AABB pretransfusion testing schemes
Type and screen
Maximum surgical blood ordering schedule
transfusion trigger for surgery
factor replacement in surgery
autologous transfusion
cell salvage
perioperative
massive transfusion protocol
Identify the etiology of perioperative hypertension.
Outline the appropriate evaluation of perioperative hypertension.
Review the management options available for perioperative hypertension
Identify the etiology of perioperative hypertension.
Outline the appropriate evaluation of perioperative hypertension.
Review the management options available for perioperative hypertension
Surgery resident postgraduate presentation on the use of blood and products presented dept of surgery, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa State, Nigeria
Transfusion Medicine has evolved in last decade & many societies have given recommendations for safe transfusion practices. Compiling these recommendations is very useful academic & practical activity
Jehowah's witnesses and blood conservation strategies by Dr.Minnu M. PanditraoMinnu Panditrao
dr. Mrs. Minnu M. Panditrao explains the problems faced by anesthesiologists in anesthetising the Jehowah's Witness patients because of their beliefs. Ina ddition she also discribes various strategies of Blood conservation.
Blood product transfusion and massive transfusionpankaj rana
Blood transfusion
Plastic bag 0.5–0.7 liters containing packed red blood cells in citrate, phosphate, dextrose, and adenine (CPDA) solution
Plastic bag with 0.5–0.7 liters containing packed red blood cells in citrate, phosphate, dextrose, and adenine (CPDA) solution
ICD-9-CM 99.0
MeSH D001803
OPS-301 code 8-80
MedlinePlus 000431
[edit on Wikidata]
Blood transfusion is generally the process of receiving blood or blood products into one's circulation intravenously. Transfusions are used for various medical conditions to replace lost components of the blood. Early transfusions used whole blood, but modern medical practice commonly uses only components of the blood, such as red blood cells, white blood cells, plasma, clotting factors, and platelets.
Manejo de hemoderivados y anticoagulacion
objetivos
-Monitoria de la coagulación
-Manejo de la anemia y el sangrado
-Manejo de la coagulación
-Terapia anticoagulante y antiplaquetaria
An Octogenarian Patient Of Intracapsular Neck Of Femur Fracture With Pre-oper...DrShinyKajal
Pre-operative Thrombocytopenia
collection and preparation of sdp single donor platelets
Hb, pt inr, platelet counts
apheresis
principle
donation criteria
sdp vs rdp
guidelines for platelet transfusion
etiologies of thrombocytopenia
isolated thrombocytopenia management
first line second line management
A case presentation of Exchange Transfusion in new born infant with Neonatal ...DrShinyKajal
A case of Exchange Transfusion in new born infant with Neonatal Jaundice and Rh incompatibility
transfusion management
double volume exchange transfusion
follow up at blood centre
antibody screening
direct antiglobulin test
technique
AABB standards
reconstituted whole blood
hyperbilirubinemia
kernicterus
encephalopathy
hematocrit and volume
Hemolytic disease of the fetus and newborn
Antigens which can cross placenta
RH immunoglobulin administration
RhIg
More Related Content
Similar to Transfusion support in Surgery- elective surgery, cardiac surgery, MSBOS, Transfusion trigger, autologous transfusion
Surgery resident postgraduate presentation on the use of blood and products presented dept of surgery, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa State, Nigeria
Transfusion Medicine has evolved in last decade & many societies have given recommendations for safe transfusion practices. Compiling these recommendations is very useful academic & practical activity
Jehowah's witnesses and blood conservation strategies by Dr.Minnu M. PanditraoMinnu Panditrao
dr. Mrs. Minnu M. Panditrao explains the problems faced by anesthesiologists in anesthetising the Jehowah's Witness patients because of their beliefs. Ina ddition she also discribes various strategies of Blood conservation.
Blood product transfusion and massive transfusionpankaj rana
Blood transfusion
Plastic bag 0.5–0.7 liters containing packed red blood cells in citrate, phosphate, dextrose, and adenine (CPDA) solution
Plastic bag with 0.5–0.7 liters containing packed red blood cells in citrate, phosphate, dextrose, and adenine (CPDA) solution
ICD-9-CM 99.0
MeSH D001803
OPS-301 code 8-80
MedlinePlus 000431
[edit on Wikidata]
Blood transfusion is generally the process of receiving blood or blood products into one's circulation intravenously. Transfusions are used for various medical conditions to replace lost components of the blood. Early transfusions used whole blood, but modern medical practice commonly uses only components of the blood, such as red blood cells, white blood cells, plasma, clotting factors, and platelets.
Manejo de hemoderivados y anticoagulacion
objetivos
-Monitoria de la coagulación
-Manejo de la anemia y el sangrado
-Manejo de la coagulación
-Terapia anticoagulante y antiplaquetaria
Similar to Transfusion support in Surgery- elective surgery, cardiac surgery, MSBOS, Transfusion trigger, autologous transfusion (20)
An Octogenarian Patient Of Intracapsular Neck Of Femur Fracture With Pre-oper...DrShinyKajal
Pre-operative Thrombocytopenia
collection and preparation of sdp single donor platelets
Hb, pt inr, platelet counts
apheresis
principle
donation criteria
sdp vs rdp
guidelines for platelet transfusion
etiologies of thrombocytopenia
isolated thrombocytopenia management
first line second line management
A case presentation of Exchange Transfusion in new born infant with Neonatal ...DrShinyKajal
A case of Exchange Transfusion in new born infant with Neonatal Jaundice and Rh incompatibility
transfusion management
double volume exchange transfusion
follow up at blood centre
antibody screening
direct antiglobulin test
technique
AABB standards
reconstituted whole blood
hyperbilirubinemia
kernicterus
encephalopathy
hematocrit and volume
Hemolytic disease of the fetus and newborn
Antigens which can cross placenta
RH immunoglobulin administration
RhIg
A Case presentation of Massive Transfusion in post LSCS PPH patientDrShinyKajal
workup at blood centre
components issued
transfusion summary
criteria for massive transfusion
goal of massive transfusion
Indication protocol for massive transfusion for whole blood, prbc, ffp, cryo, platelets
Targets of resuscitation in massive blood loss
Complications of Massive Transfusion
citrate toxicity
lethal triad
case presentation on diagnosis of beta thalassemia majorDrShinyKajal
case history of 9 month old infant
Paediatric Clinical Approach to this case
examination
workup at blood centre
HPLC screening
laboratory findings
screening of father mother
prominent facial features
PBF and bone marrow findings
usg abdomen
xray skull
prbc transfusion therapy in thalassemia major
classification of thalassemia
national burden in india
pathogenesis- anemia skull bone iron overload
world thalassemia day
Troubleshooting in Transfusion transmissible infection TTI laboratoryDrShinyKajal
Checklist of categories for troubleshooting in TTI
Factors affecting Troubleshooting in TTI Lab
controls used in assay testing
Principles and Practices of ELISA and Rapid for TTI Screening
Equipment Management in TTI Laboratory
calibration of equipments used
Documentation and Records in TTI Laboratory
Root Cause Analysis and Process Improvement in TTI Laboratory
External Quality Assessment Scheme and Proficiency Testing
Waste management in transfusion centre
Principle of Troubleshooting in TTI Lab
Case presentation onHeterozygous variant of Hemoglobin EDrShinyKajal
case presentation on heterozygous hemoglobin E
investigations
HPLC high performance liquid chromatography test
HbA2
fetal hemoglobin values in different variants of hempglobin
hemoglobinopathies
HbS, HbE, HbD
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?DrShinyKajal
Blood group antibodies
different reaction grades
test material required for antibody identification
procedure
antibody screening using 2-3 cell panel
antibpdy identification using 11 cell panel
immediate spin phase
37 degree c
ahg phase
check cells
interpretation antibody workups
enzyme technique
Tissue Banking and Umbilical Cord Blood BankingDrShinyKajal
Umbilical cord blood vs bone marrow vs peripheral stem cells
indications of stem cell transplant
Regulatory requirements for cord blood banking
Requirements for processing, testing and storage areas for UCB
Air-handling system
Personnel for Cord Blood Bank
Collection of processed UCB component
procedure- in utero ex utero
transportation
processing
freezing
storage
screening tests
quality control
advantages and disadvantages
labelling
tissue collection
live and deceased donors
pathogen inactivation of cellular components.pptxDrShinyKajal
Chemical inactivation
Photo-inactivation
Solvent-detergent Plasma
Photosensitizers
Methylene Blue light treatment
Psoralen Ultraviolet Light Treatment
Riboflavin Light Treatment
INTERCEPT System
Mirasol system
Platelet and plasma Pathogen Inactivation
FRALE and azridine compounds
1. Bio preservation of Red Cell Components 2. CULTURED RBCs 3. solvent plasmaDrShinyKajal
1. Bio preservation of Red Cell Components
2. CULTURED RBCs
3. Solvent plasma
Hypothermic storage
Cryopreservation
Lyophilization
Desiccated RBCs
Three major sources of cells are under consideration:
circulating stem and progenitor cells from adults or from cord blood
immortalized progenitors
pluripotent stem cells.
Immortalized Progenitors
LIQUID CULTURE METHODS- by the SED (stem cell factor (SCF), erythropoietin, and dexamethasone) and STIF cocktails (stem cell factor, thombopoietin, insulin-like growth factor-2, fibroblast growth factor-2)
ENUCLEATION- separation of extruded nuclei from cRBCs
SCALING UP- using cord blood CD34+ cells in bioreactors
and treated for 4 h with TNBP (tri-nitrobutylphosphate)solvent and with Triton X-100 detergent
Storage of Blood Components- equipments, effects of improper storage, transpo...DrShinyKajal
Introduction
Equipments required
Harmful effects of improper storage
Storage of various blood components- AABB guidelines
NACO guidelines for storage
Storage during transport
Storage in frozen state
Physical and chemical changes in stored blood
Human Stem Cells- Introduction
Types of HSC transplants
Indications
Sources of stem cells
Collection and mobilization
Types of Mobilizing agents
Processing
Cryopreservation and storage
PBSC Transplant
Quality control
Complications
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...kevinkariuki227
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edition by Laurie Kennedy-Malone, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edition by Laurie Kennedy-Malone, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Mastering Wealth: A Path to Financial FreedomFatimaMary4
### Understanding Wealth: A Comprehensive Guide
Wealth is a multifaceted concept that extends beyond mere financial assets. It encompasses a range of elements including money, investments, property, and other valuable resources. However, true wealth also includes non-material aspects such as health, relationships, and personal fulfillment. This guide delves into the various dimensions of wealth, exploring how it can be created, sustained, and enjoyed.
#### Defining Wealth
Traditionally, wealth is defined as the abundance of valuable resources or material possessions. It includes financial assets like cash, savings, stocks, bonds, and real estate. However, a broader understanding of wealth considers factors such as personal well-being, emotional health, social connections, and intellectual growth. This holistic view recognizes that true wealth is not solely about accumulating money but also about enhancing one's quality of life.
#### The Importance of Financial Wealth
Financial wealth remains a critical component of overall wealth. It provides security, freedom, and the ability to pursue opportunities. Key elements of financial wealth include:
1. **Savings**: Money set aside for future use. It is crucial for emergencies, large purchases, and financial goals.
2. **Investments**: Assets purchased with the expectation that they will generate income or appreciate over time. Common investments include stocks, bonds, mutual funds, real estate, and businesses.
3. **Income**: Regular earnings from work, investments, or other sources. Consistent income is essential for maintaining and growing wealth.
4. **Debt Management**: Effectively managing debt ensures that it does not erode financial wealth. This includes paying off high-interest debt and using credit wisely.
#### Creating Wealth
Creating wealth involves generating and accumulating financial and non-financial resources. The process can be broken down into several key strategies:
1. Education and Skill Development: Investing in education and skills enhances earning potential. Higher education, professional certifications, and continuous learning can lead to better job opportunities and higher salaries.
2. Entrepreneurship: Starting and running a successful business can be a significant source of wealth. Entrepreneurship requires innovation, risk-taking, and effective management.
3. Investing: Making smart investments is essential for wealth creation. This involves understanding different types of investments, assessing risks, and making informed decisions. Diversifying investments can reduce risk and increase potential returns.
4. Saving and Budgeting: Effective saving and budgeting help accumulate wealth over time. Setting financial goals, creating a budget, and sticking to it are foundational steps in wealth creation.
5. Real Estate: Investing in property can provide rental income and capital appreciation. Real estate is a tangible asset that can hedge against inflation
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
EATING DISORDERS (Psychiatry-7)by dr Shivam sharma.pptxShivam Sharma
For any queries ,contact shvmshrm@outlook.com
---
## Introduction to Eating Disorders
Welcome to this comprehensive presentation on Eating Disorders, a critical and often misunderstood area of mental health. This presentation is designed to provide in-depth knowledge and insights into the various aspects of eating disorders, making it valuable for both postgraduate medical aspirants preparing for the INI-CET and the general public seeking to understand these complex conditions.
### Objectives:
1. **Understanding Eating Disorders**: Gain a clear understanding of what eating disorders are, their types, and their distinguishing characteristics.
2. **Etiology and Risk Factors**: Explore the underlying causes and risk factors that contribute to the development of eating disorders.
3. **Clinical Features and Diagnosis**: Learn about the clinical features, diagnostic criteria, and the importance of early detection.
4. **Management and Treatment**: Review the current approaches to managing and treating eating disorders, including medical, psychological, and nutritional interventions.
5. **Prevention and Awareness**: Discuss strategies for prevention, early intervention, and increasing awareness about eating disorders.
This presentation aims to bridge the gap between academic knowledge and practical understanding, providing you with the tools to recognize, diagnose, and effectively manage eating disorders. Whether you are preparing for a medical exam or seeking to educate yourself or others about these serious conditions, this presentation will equip you with essential information and practical insights.
Let's begin our journey into understanding eating disorders and the significant impact they have on individuals and society.
---
For any queries ,contact shvmshrm@outlook.com
2. INDEX
I. AABB indications
II. Elective surgeries- Maximum surgical blood ordering schedule
III. Anemia and surgery- including Transfusion Trigger
IV. Surgery and coagulation disorders- including factor replacement
V. Transfusion in cardiac surgeries- including autologous transfusion
VI. Patient Blood management in surgery
3. •In general surgery, blood transfusions are given to improve oxygen delivery to
tissues, based on the patient's physiological requirements.
•Under normovolemic conditions, the body responds to a loss of haemoglobin by
increasing the cardiac output, which affect hemodynamics during surgery.
4. Indications for Transfusion in surgery
Severe haemorrhage
Preoperatively anaemia correction
During major operation in which blood loss is inevitable
Postoperative anaemia
To arrest haemorrhage or as a prophylactic measure prior to operation in patients with
haemorrhagic status
Anaemia from chronic surgical conditions
5. Some surgical transfusion strategies include:
Allogenic Transfusion
Autologous Transfusion- Intra And Postoperative Red Cell Salvage, Haemodilution
Blood Substitutes
Haematopoietic Factors
Antifibrinolytics
Fibrin Sealants
Conjugated Oestrogens.
6. I. AABB Indications
In 2012, the American Association of Blood Banks (AABB) published their
clinical practice guidelines on the transfusion of RBCs, with recommendations
graded according to their level of evidence:
(1)The AABB recommends adhering to a restrictive transfusion strategy.
•In adult and paediatric ICU patients, transfusion should be considered at Hb
concentrations of 7g/dL or less.
•Quality of evidence: high; strength of recommendation: strong.
7. (2) In hospitalized, haemodynamically stable patients with pre-existing cardiovascular
disease, the AABB suggests adhering to a restrictive transfusion strategy.
•Transfusion should be considered at a Hb concentration of 8g/dL or less or for
symptoms (chest pain, orthostatic hypotension or tachycardia unresponsive to fluid
resuscitation, or congestive heart failure).
•Quality of evidence: moderate; strength of recommendation: weak.
8. (3) In hospitalized, haemodynamically stable patients with acute coronary
syndrome, the AABB cannot recommend for or against a liberal or restrictive
RBC transfusion threshold. Further research is needed to determine the optimal
threshold. Quality of evidence: very low.
(4) In hospitalized, haemodynamically stable patients, transfusion decisions
should be influenced by symptoms as well as haemoglobin concentration.
9. These recommendations are applicable in most postoperative patients, and also in
non-surgical patients, with the exception of patients with acute coronary
syndrome.
Transfusion should also be restricted in patients following an autologous blood
transfusion programme.
10. II. Transfusion practice in elective surgeries
Nowadays there is minimum blood loss during surgery because of meticulous
surgical techniques, use of tourniquets, use of vasoconstrictors, use of
antifibrinolytic drugs and good anaesthetic techniques.
For effective utilization of blood during surgical procedures and haemorrhage,
the clinician should have the knowledge about the blood volume of an individual
which is about 70 ml/kg in an adult male, 66 ml/kg in an adult female, 80 ml/kg
in children and 85 ml/kg in neonates.
11. Other points of consideration before transfusion
An average healthy individual with normal cardiovascular system can withstand
a loss of up to 500 ml of blood without any ill effects.
A healthy average adult may lose up to 1000 ml of blood or even more without
any ill effects, provided circulating blood volume is maintained by crystalloid or
colloid solutions.
Unnecessary transfusions especially of single unit of blood should be avoided in
surgeries.
12. Role of Surgical Blood Ordering Practices in
Elective Surgeries
•Component outdate rates are influenced by surgical ordering practices.
•For example, when RBC units are crossmatched for surgical patients, the shelf life of the
unit is shortened if the component is unused.
•When crossmatch to-transfusion (C:T) ratios are monitored, a C:T ratio of >2.0 may
indicate excessive ordering of crossmatched blood.
• One approach to reducing excessive C:T ratios is to identify procedures that do not
typically require blood, and use this information to develop guidelines for the use of type
and screen units instead of crossmatched units.
13. The policy of type and screen should be adopted universally for all patients even if they
don't currently require blood (e.g. cholecystectomy).
The request for single unit of blood in surgery is a common practice in India which by and
large has been seen as an act of thoughtlessness.
To avoid this-
Transfusion trigger may be lowered to 7.5 gm/dl of Hb and should be based on the rate of
development of anaemia and assessment of its effects on prognosis.
Each blood transfusion service should frame its Maximum Surgical Blood Order Schedule
14.
15.
16. III. Anemias and surgery
Most of the patients of elective surgery are anemic which are mostly Nutritional
deficiencies (iron and folate).
Many clinicians now accept the Hb of 7.5 g/d as transfusion trigger or the
preoperative Hb threshold in a well-compensated patient presenting for surgery.
17. •A higher pre-operative Hb level is required for elective surgery in following situations:-
•Inadequate compensation for anemia and the oxygen supply to tissues- Evidence of angina
•Increasing dyspnea or dependent oedema
•Patients with co-existing cardio respiratory disease like ischemic heart disease
•Major surgery or anticipated significant blood loss.
•Blood transfusion should rarely be used preoperatively to facilitate elective surgery.
18. Transfusion Trigger- Surgery
The intraoperative transfusion strategy should be based on patient’s Hb or
haematocrit concentration, amount of blood loss, haemodynamic changes or end-
organ ischaemia.
They recommended a Hb target 7.0–9.0 g/dL and a transfusion trigger of 7.5 g/dL.
The transfusion trigger for patients on cardiopulmonary bypass with moderate
hypothermia and those at risk of critical end-organ ischaemia is 6.0–7.0 g/dL.
In case of ongoing bleeding, a haematocrit of less than 30% is recommended as a
transfusion trigger.
19. Haemoglobin trigger in Cardiac surgery
•The Society of Thoracic Surgeons and Society of Cardiovascular 2011 guidelines
recommended PRBC transfusion for Hb <6 g/dL during cardiopulmonary bypass
and <7 g/dL post-operatively, except in patients at risk for decreased cerebral
oxygen delivery, for whom a higher Hb level is recommended.
•A restrictive Hb of 7-8 gm/ dl (Hct 21-24%) with a patient maintaining an
adequate O2 delivery > 273 ml O2/min/m2 can be considered during
cardiopulmonary bypass.
20.
21.
22.
23. IV. Surgery and coagulation disorders
•Diagnosis and treatment of coagulation disorders prior to any surgical procedure
by haematologist is important to prevent excessive operative blood loss, which
may lead to uncontrolled haemorrhage during surgery.
•INR should be less than 2 before surgery commences.
•Some drugs like aspirin and NSAIDS interfere with platelet function, thus
stopping of such drugs 5-6 days before surgery can significantly reduce operative
blood loss.
24. Factor replacement in surgery
Factor replacement on demand shall be performed during spontaneous or
traumatic bleeding episodes
Dose (Factor VIII):
Bleeding into joints and muscles (30-40 IU/kg)
life-threatening (80-100 IU/kg),
surgery (major bleeding 80-100 IU/kg)
minor wounds (50-100 IU/kg)
25. For surgical prophylaxis,
Factor VIII and IX levels should be maintained above 50% for 7-15 days after surgery
The plasma fibrinogen levels of at least 1 g/L should be aimed from beginning prior to
surgery and continued till wound healing.
26. Albumin in Surgery
Cardiac surgery: Last choice of treatment after crystalloids and non-protein colloids
•Major surgery: Not in the immediate postoperative period. The only indication for
use is albumin less than 2 g/dL after normalization of circulatory volume
27. V. Blood transfusion in cardiac surgery
•Autologous blood transfusion is the most commonly used transfusion protocol.
•Acute isovolemic haemodilution improves microcirculatory blood flow due to decrease in
the viscosity of blood.
•Use of cell saver machine helps to use the intra-operative mediastinal shed blood safely.
•There is no indication to use freshly drawn blood. The concept that transfusion of fresh
blood reduces bleeding during cardiac surgery is no longer accepted.
•Blood components- platelets or FFP are not routinely used during cardiac surgery.
28. Pre-operative transfusion in Surgery
•Preoperative erythrocyte transfusion is not routinely recommended in elective surgeries.
•However, it is used in emergency surgery and life-threatening anaemia.
•Oral or intravenous iron alone may be considered in mildly anaemic patients (women-
Hb 10–12 g/dl; men- Hb 10–13 g/dl) or in severely anaemic patients (both genders, Hb
< 10 g/dl) to improve erythropoiesis prior to surgery.
•Erythropoietin with iron supplementation should be considered to reduce postoperative
transfusions in patients with non-iron deficiency (e.g., EPO, vitamin D or folate)
29. Pre-operative autologous blood donation
•In patients posted for elective surgery with Hb > 11 gm/dl and without severe aortic stenosis or an acute
coronary syndrome within 4 weeks.
Some of the indications of preoperative autologous blood deposit may include:
• Orthopaedic surgery (joint replacement)
• Plastic and reconstructive surgery
• Cardiovascular surgery
• Major abdominal surgery (elective splenectomy)
• Individuals with rare blood group/ with multiple alloantibodies/antibodies to high-frequency antigens
30. Contraindications for preoperative autologous blood
donation:
• Bacteraemia and/or acute localized infection
• Myocardial infarction in the past 6 months
• Unstable angina / angina at rest
• Aortic stenosis
• Congestive heart failure
• Significant ventricular arrhythmia
• Marked uncontrolled hypertension
• Cerebrovascular accident within 6 months
• Transient ischemic attack
31. Perioperative autologous blood donation
Acute normovolemic haemodilution:
It involves removing whole blood from the patient into a standard blood bag
containing anticoagulant, either immediately before or shortly after the induction
of anaesthesia in the OT with the maintenance of normovolemia using crystalloid
and colloid replacement.
32. Perioperative Reinfusion:
•Patients of ANH should be monitored regularly during surgery, and the decision of
reinfusion depends on the anaesthesiologist’s/surgeon’s assessment of blood loss.
•Usually, blood is reinfused when haemoglobin level falls in the range of 7-8 g/dl.
•The units of blood are reinfused to the patient in the reverse order of collection- This
allows the most concentrated unit to be transfused at the time of least bleeding.
•Hence, the first unit, containing the highest haemoglobin, the maximum number of
platelets and undiluted coagulation factors, is administered last.
33. Intraoperative blood salvage
•The process of collecting shed autologous blood and its processing and re-
administration has been termed as cell salvage, auto transfusion, intraoperative blood
recovery, and cell saving.
•It can happen either in the intraoperative period or in the post-operative period.
•Salvage involves washing of the collected blood, or it may be simply re-administered
with micro aggregate filtration.
•Blood salvage in surgical procedures is recommended if there is the expectation of a
significant blood loss (greater than 1 litre).
34.
35. Postoperative blood salvage
•Postoperative blood salvage refers to collecting blood from surgical drains and subsequent
reinfusion through a 40-micron microaggregate filter, with or without washing.
•These techniques available for collecting the postoperative drainage are usually of worth
if blood collection can be done within 24 to 48 hours after surgery in patients actively
bleeding into a closed site.
This practice is generally limited to cardiac and orthopedic surgery.
36.
37. Transplantation surgeries
Before surgery, a crossmatch between recipient serum and donor lymphocytes is required.
The ASHI Standards for Accredited Laboratories requires that the crossmatch be performed
using a method that is more sensitive than routine microlymphocytotoxicity testing, such as
prolonged incubation, washing, augmentation with AHG reagents, or flow cytometry
Because HLA antibody responses are dynamic, the serum used for the crossmatch is often
obtained within 48 hours of surgery for sensitized potential recipients and is retained in the
frozen state for any required subsequent testing.
An incompatible crossmatch with unfractionated or T lymphocytes is typically a
contraindication to transplantation surgeries.
38. Equipments common in surgical
transfusions
•Blood warmers are used when rapid transfusion of components is required,
especially in massive blood loss during surgery settings.
•Microaggregate filters are typically used for the reinfusion of shed autologous
blood collected during or after surgery.
39. VI. Patient Blood Management
•The concept of patient blood management introduced by the WHO in 2011 is a systematic
approach focused on weighing the benefits of transfusion against the risk, with minimal
transfusion-related adverse events.
•Perioperative blood management is based on a thorough preoperative assessment of patients
by correcting any reversible cause of anaemia instead of going for allogenic transfusion.
•Preoperative blood transfusions are recommended only in patients with persistent bleeding,
urgent or emergency surgery or cancer-related surgery where surgery cannot be delayed.
40.
41.
42.
43. References
1) AABB (Association for the Advancement of Blood and Biotherapies) Technical Manual, 21st edition, 2023
2) Modern Blood Banking & Transfusion Practices. Denise M. Harmening 7th Edition. 2019.
3) Principles and practice of Transfusion Medicine by Dr. R. Makroo, 2nd Edition (2019)
4) Transfusion Medicine, Technical Manual. DGHS, Ministry of Health and Family Welfare Govt. of India. 3rd
Edition. 2022